The social campaign aimed to defy stigma, give voice to patients and care providers and pave the way for the launch of a ...

Wilson celebrates the first U.S. patient to complete gene therapy for sickle cell, but says advocacy must continue.

Sickle cell drug voxelotor, was approved for use by the NHS in May, only to be removed from distribution by Pfizer last month. It follows the removal of another drug, crizanlizumab in January ...

High-yield dividend stocks have been gaining momentum ahead of potential Fed rate cuts. While sticky inflation and possible ...

Pfizer's reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics (GBT) has been confirmed, with the $68.50-per-share deal valuing GBT at $5.4 billion. As we ...

The Ministry of Health (MoH) has launched two landmark documents to enhance healthcare outcomes in Ghana: the National Sickle Cell Disease Strategy for 2024-2028 and the National Vaccine Policy.

Centessa had recently conducted an interim analysis of a phase 2 study of its drug, called SerpinPC, which is designed to ...

Almost a year after two historic approvals, Pfizer is pulling a sickle cell disease treatment from the market, and the ...

in patients aged 12 years and older who have sickle cell disease. However, just weeks ago Pfizer pulled the drug in a voluntary market withdrawal over its potential impacts on those taking it ...